Anocca AB
556946-2384ActiveEngineering precision T-cell immunotherapies for hard-to-treat cancers.
Overview
- 100–199
- Employees
- 750–999K SEK
- Revenue
- 2013
- Founded
Key Decision Makers
Jacob Michlewicz
Chief Financial Officer
Niclas Sandberg
Head of Quality Control
Mattias Persson
Head of Engineering
Mikael Blomqvist
Board Member
+34 more contacts in Funnelfeedr
Description
Anocca AB is a fully integrated, clinical-stage biopharmaceutical company based in Sweden. The organization specializes in creating libraries of T-cell receptor-engineered T cell (TCR-T) therapies. Their core mission is to redefine the treatment landscape for solid tumors, as well as infectious and...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Bioteknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556946238401
Decision Makers
38 contacts in FunnelfeedrJacob Michlewicz
Chief Financial Officer
Niclas Sandberg
Head of Quality Control
Mattias Persson
Head of Engineering
Mikael Blomqvist
Board Member
Martin Welschof
Board Member
Fredrik Hansson
Board Member
Sophie Blomqvist
Board Member
Mark Farmery
CDO
Christiane Hanke-Harloff
Board Member
Hans Stråberg
Chairman of the Board
Ragnar Lindqvist
Board Member
Luke Pase
Chief Technology Officer
Ryan Hill
Chief Information Officer
Zach Chia
VP Strategy & Business Development
Jan Lundberg
Board Member
Viktor Arnkil
Chief Operating Officer
Zahid Bashir
Chief Medical Officer
Reagan Jarvis
Chief Executive Officer, Scientific founder
Hugh Salter
Chief Scientific Officer
Niklas Sjökvist
Head of Production
Rehab Alnabhan
Clinical Science Lead
Mikael Pedin
HR Manager
Sheila Forsman
Director of Clinical Development
Malin Löfdahl
Director of GMP Operations
Dennis Ahlstedt
IT Manager
Athina Totomi
Platform Project Manager
Other Contacts
Sergey Zelenin
Principal Scientist
Richard Samuelson
Lead Software Engineer
Shenqiu Wang
Senior Scientist
Hannes Uchtenhagen
Principal Scientist
+8 more contacts in Funnelfeedr
Similar Companies
20 similar companies in FunnelfeedrCuraCell Holding AB
European biotech developing personalized T-cell therapies for solid cancer tumors.
Alvotech Sweden AB
20–49 employeesDeveloping and manufacturing affordable biosimilars to expand global medicine access.
Lokon Pharma AB
10–19 employeesDeveloping novel gene engineering vectors for cancer immunotherapy.
Asgard Therapeutics AB
10–19 employeesPioneering in vivo cell reprogramming for next-generation cancer immunotherapy.
Valo Therapeutics Oy
Developing novel peptide-coated oncolytic virus immunotherapies for cancer.
Browse More
Anocca AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo